Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer

Clinical Lung Cancer

Volumn 8, Issue 9, 2007, Pages 554-561

  Greillier, Laurent ^a   Thomas, Pascal ^a   Loundou, Anderson ^a   Doddoli, Christophe ^a   Badier, Monique ^a   Auquier, Pascal ^a   Barlési, Fabrice ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Forced expiratory volume; Postoperative complications; Quality of life

Indexed keywords

ADULT; AIRWAY RESISTANCE; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RESIDUAL VOLUME; SCORING SYSTEM; THORAX SURGERY; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 37349038355     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2007.n.042     Document Type: Article

References (35)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2:533-43.
2. Goldstraw P, Crowley J, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; participating institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:706-14.
3. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 1992; 101:1332-7.
4. Doddoli C, Barlesi F, Trousse D, et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 2005; 130:416-25.
5. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89-108.
6. Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003; 123:105S-14S.
7. Mazzone P, Arroliga A. Lung cancer: preoperative pulmonary evaluation of the lung resection candidate. Am J Med 2005; 118:578-83.
8. Boushy SF, Billig DM, North LB, et al. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest 1971; 59:383-91.
9. Miller JI, Jr. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg 1993; 105:347-51.
10. Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity ptedicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 1988; 96:894-900.
11. Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg 1999; 117:581-6.
12. Pierce RJ, Copland JM, Sharpe K, et al. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994; 150:947-55.
13. Bolliger CT, Wyser C, Roser H, et al. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest 1995; 108:341-8.
14. Holden DA, Rice TW, Stelmach K, et al. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest 1992; 102:1774-9.
15. Barlesi F, Doddoli C, Loundou A, et al. Preoperative psychological global well being index (PGWBI) predicts quality of life for patients with non-small cell lung cancer managed with thoracic surgery. Eur J Cardiothorac Surg 2006; 30:548-53.
16. Dales RE, Belanger R, Shamji FM, et al. Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 1994; 47:1443-9.
17. Handy JR, Jr, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002; 122:21-30.
18. Win T, Sharples L, Wells FC, et al. Effect of lung cancer surgery on quality of life. Thorax 2005; 60:234-8.
19. Zieren HU, Muller JM, Hamberger U, et al. Quality of life after surgical therapy of bronchogenic carcinoma. Eur J Cardiothorac Surg 1996; 10:233-7.
20. Hendriks J, Van Schil P, Van Meerbeeck J, et al. Short term survival after major pulmonary resections for bronchogenic carcinoma. Acta Chir Belg 1996; 96:273-9.
21. Myrdal G, Valtysdottir S, Lambe M, et al. Quality of life following lung cancer surgery. Thorax 2003; 58:194-7.
22. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-38.
23. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26:511-22.
24. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26:720-35.
25. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Work group on standardization of respiratory function tests. European community for coal and steel. Official position of the European Respiratory Society. Rev Mal Respir 1994; 11(suppl 3):5-40.
26. Barlesi F, Boyer L, Doddoli C, et al. The place of patient satisfaction in quality assessment of lung cancer thoracic surgery. Chest 2005; 128:3475-81.
27. Osoba D, Aaronson N, Zee B, et al. Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The study group on quality of life of the EORTC and the symptom control and quality of life committees of the NCI of Canada Clinical Trials Group. Qual Life Res 1997; 6:103-8.
28. Dupuy H. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, et al, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, NY: Le Jacq Publ Inc; 1984:170-83.
29. Watanabe S, Asamura H, Suzuki K, et al. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004; 78:999-1002.
30. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139:02-910.
31. Win T, Jackson A, Sharples L, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J 2005; 25:594-9.
32. Gerbase MW, Spiliopoulos A, Rochat T, et al. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005; 128:1371-8.
33. Paull DE, Thomas ML, Meade GE, et al. Determinants of quality of life in patients following pulmonary resection for lung cancer. Am J Surg 2006; 192:565-71.
34. Barlesi F, Barrau K, Doddoli C, et al. Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective. Rev Mal Respir 2006; 23:489-96.
35. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005; 127:1873-5.